The rate of tumor tissue shrinkage, the survival time of mice, and the lactate content in transplanted tumor tissues were subsequently measured, and the results showed that mice treated with the MCT1 inhibitor in combination with radiotherapy had significantly smaller tumors, longer survival time, and higher intratumoral lactate levels than mice in the radiotherapy alone group. This evidence concerns the gene SLC16A1 and neoplasm.